1.中国药科大学江苏省药物分子设计与成药性优化重点实验室,南京 211198;2.中国药科大学药学院,南京 211198
R914
国家自然科学基金资助项目(No.82173673,No.81872799);江苏省自然科学基金资助项目(No.BK20191321)
1.Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 211198;2.School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
This study was supported by the National Natural Science Foundation of China (No.82173673, 82173673); and the Natural Science Foundation of Jiangsu Province (No.BK20191321)
陈鑫,杨倩,尤启冬,郭小可.靶向MLL1-WDR5蛋白-蛋白相互作用抑制剂的研究进展[J].中国药科大学学报,2022,53(2):125-136.
Cite:CHEN Xin, YANG Qian, YOU Qidong, GUO Xiaoke. Advances of inhibitors targeting MLL1-WDR5 protein-protein interaction[J]. J China Pharm Univ,2022,53(2):125-136.